Phathom Pharmaceuticals, Inc. PHAT Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s total liabilities & equity?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total liabilities & equity of $305.12M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s total liabilities & equity changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total liabilities & equity increased by 3.7% year-over-year, from $294.21M to $305.12M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s total liabilities & equity has grown at a -2.6% compound annual growth rate (CAGR), from $295.11M to $259.15M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.